Institute for Cancer Research


Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.

The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.

Gunnar Sæter<br>Scientific director
Gunnar Sæter
Scientific director

Scientific production - Institute for Cancer Research

  Publications Doctoral theses
2015 so far  
2014 197  
2013 199 27
2012 175 18
2011 201 22
2010 221 11
2009 182 21
2008 152 11

Department overview


Latest news

WiBEC (Wireless In-Body Environment Communications) selected for funding by EU

New EU H2020- MARIE Sklodowska-CURIE ACTIONS project coordinated by The Intervention Centre

I. Balasingham
I. Balasingham

WiBEC (Wireless In-Body Environment Communications), an Innovative Training Network for 16 young researchers, has been selected for funding by the European Commission under the H2020- MARIE Sklodowska-CURIE ACTIONS (MSCA-ITN-2015).
The beneficiaries are Oslo University Hospital with professor Ilangko Balasingham (photo) as coordinator, Sorin CRM, France, Universitat Politechnica de Valencia, Spain, Technische Universität Dresden, Germany, Ovesco AG, Germany, Norges tekninsk-naturvitenskapelige universitet, Norway, ValoTec, France, and Instituto de Investigación Sanitaria La Fe, Spain.


OUS research blog:

Improved methods for the treatment of metabolic diseases affecting children's nervous system

Petter Strømme and Gro Anita Gauslå
Petter Strømme and Gro Anita Gauslå

The latest OUS research blog is written by Petter Strømme and Gro Anita Gauslå from the Department of Clinical Neurosciences for Children at the Woman and Children's Division at OUS. The blog is entitled "Grave metabolic diseases may be treated" and discusses how chronic and incurable diseases that affect children's nervous system now may be treated with increasingly good results.


Åsmund Eikenes publishes careers column in Nature

Å. Eikenes
Å. Eikenes

Åsmund Eikenes from Harald Stenmark's lab at the department of Molecular Cell Biology has written a column in the careers section of the May 6th edition of Nature (journal impact factor 42.4). The article is entitled "Visual maps bring research to life".

In the short essay, Åsmund argues that scientists could benefit from actively using techniques from storytelling to improve their scientific work.


Public health improvement:

Many OUS teams in the Holmenkollstafetten 2015

The Molecular Oncology relay team
The Molecular Oncology relay team

About 40 teams from Oslo University Hospital participated in this year's Holmenkollstafetten, Norway's largest sport event in number of participants (about 51 000).  With 15 members on each team, each running between 390 and 2800 meters, this relay race acts as an inspiring annual event, triggering activities at the work places before and after the race, contributing to the improvement of the general public health at the institution. It is not the running of the particular stretch on race day that is important in this respect, it is the training leading up to the event that can make a difference. The Holmenkollstafetten has become an important social happening for many departments at the hospital.


Oslo University Hospital honouring excellent research

Award winners during the ceremony
Award winners during the ceremony

Three scientists received awards for their outstanding work at a ceremony taking place at Oslo University Hospital April 24th. The major prize - the "Excellent Researcher Award" - went to professor Anne-Lise Børresen-Dale. Jan Terje Andersen and Jon Arne Dahl both received the "Early Career Award". The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities. This is the third year such prizes have been distributed in order to honour excellent scientific achievements.


OUS research blog from Anja Nilsen:

More precise cancer treatment by use of RNA biomarkers

Anja Nilsen
Anja Nilsen

In a recent OUS research blog article (in Norwegian) Anja Nilsen (PhD) from Heidi Lyng's Clinical Radiation Biology group at the Departement of Radiation Biology at the Institute for Cancer Research writes about cancer treatment and how the use of RNA as biomarkers may be useful in order to give more precise radiation doses as well as to improve the targeting of chemotherapy.